Dinan Michaela A, Weinfurt Kevin P, Friedman Joëlle Y, Allsbrook Jennifer S, Gottlieb Julie, Schulman Kevin A, Hall Mark A, Dhillon Jatinder K, Sugarman Jeremy
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC 27715, USA.
Account Res. 2006 Oct-Dec;13(4):325-42. doi: 10.1080/08989620601003414.
The authors reviewed the conflict of interest policies of 9 academic medical centers in the United States and interviewed members of the Institutional Review Boards (IRBs) and Conflict of Interest Committees (COICs) at those institutions. They found that many institutions used processes for reporting and managing conflicts of interest that were more decentralized than the processes described in their policies. Also, most institutions had no clear and comprehensive policy to guide investigators regarding disclosure of conflicts of interest to potential research participants. Considerable differences in understanding of conflict of interest policies were observed between IRB and COIC officials.
作者们审查了美国9家学术医疗中心的利益冲突政策，并采访了这些机构的机构审查委员会（IRB）和利益冲突委员会（COIC）的成员。他们发现，许多机构用于报告和管理利益冲突的流程比其政策中描述的流程更加分散。此外，大多数机构没有明确和全面的政策来指导研究人员向潜在研究参与者披露利益冲突。IRB和COIC官员在对利益冲突政策的理解上存在相当大的差异。
